Odilorhabdins Bind to Ribosomes and Disrupt Protein Synthesis in Bacteria
Exciting new discovery describes the mechanism of action of a new class of antibiotics
Exciting new discovery describes the mechanism of action of a new class of antibiotics
CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis
Copley Scientific joins IPAC-RS to drive innovations in the field of OINDPs
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix
AI 'scientist' finds that toothpaste ingredient may help fight drug-resistant malaria
Multiplex biochemical assays, sometimes customized, help develop the toxicity profile and selection of agrochemicals before they enter the R&D process
Prof. Patrick Gunning, Thermo Fisher Scientific, LGC and BioTek among those recognized at SelectScience's special 20th Anniversary Awards Party
SelectScience is attending SLAS 2018 in San Diego, USA, where we will host the Scientists’ Choice Awards for Drug Discovery at our special 20th Anniversary Party
A laboratory in Australia is using advanced spectrometry approaches to harness the potential of natural metabolites from marine invertebrates in drug discovery
ADVANCE trial expected to initiate patient recruitment shortly in several other EU countries, followed by the US
To be in with a chance of winning a $500/£400/450 € Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your laboratory in 2017
Subsidiaries merge to become Bruker Japan K.K
Which new product, instrument or consumable made the most difference to your laboratory?
Trial will analyze breath biomarkers to improve understanding of the treatment effects of a novel GSK pipeline drug candidate for COPD
A new hope for Psoriasis sufferers and difficult-to-treat dermatological diseases
Experts share important considerations that can help to improve reproducibility of preclinical research
Plans in pipeline to build a dedicated continuous bioprocessing facility in Fribourg, Switzerland, featuring Pall Life Sciences’ Cadence platform technologies
Helperby's ARB technology rejuvenates existing antibiotics to outsmart antibiotic resistance